WI-38 is a line of human lung cells developed in 1962 that became the foundation for some of the most widely used vaccines in history, including those against rubella, rabies, and adenovirus. The cells were derived from fetal lung tissue at the Wistar Institute in Philadelphia by the biologist Leonard Hayflick, and their influence extends well beyond vaccines: they helped overturn a longstanding belief about how cells age and continue to serve as a workhorse in aging research today.
Where WI-38 Cells Came From
In 1962, Leonard Hayflick established the WI-38 cell strain from the lung tissue of an aborted fetus in Sweden. “WI” stands for the Wistar Institute, where the work was done, and “38” refers to the 38th fetal tissue sample in the series. The cells were normal human diploid fibroblasts, meaning they had a standard set of chromosomes and behaved like regular human cells rather than like tumor-derived or otherwise transformed laboratory lines.1AIMS Press. The Role of the WI-38 Cell Strain in Saving Lives and Reducing Morbidity
This distinction mattered enormously. Before WI-38, many vaccines were grown in cells from monkey kidneys. Those animal-derived cells sometimes harbored hidden viruses that could contaminate the final vaccine product. A human cell strain with a known, clean history offered a safer alternative. The fact that WI-38 cells were normal rather than cancerous also meant they could be rigorously characterized, banked in frozen vials, and tested for safety before being used to manufacture vaccines at scale.
The Discovery That Cells Have a Finite Lifespan
Before Hayflick’s work, the prevailing dogma in biology held that normal cells could replicate indefinitely when kept in culture. This idea traced back to the early 20th century, and it was widely accepted. WI-38 cells helped demolish it. Hayflick and his colleague Paul Moorhead observed that WI-38 fibroblasts could divide only about 50 times before they stopped, entering a state of permanent growth arrest.2PubMed. The cell biology of aging This finite replication capacity became known as the Hayflick limit, and it launched an entirely new field: the cellular biology of aging.
The key insight was that normal human cells are fundamentally different from cancer cells or other abnormal lab lines. Normal cells have a built-in countdown. Abnormal lines can keep dividing forever, but that indefinite growth is itself a sign of abnormality, not a feature of healthy biology.3Experimental Cell Research. The limited in vitro lifetime of human diploid cell strains This reframing was crucial for aging research. It meant scientists studying how cells age needed to work with normal cells, not immortalized ones, if they wanted their findings to reflect what actually happens in the human body.
Why the Cells Eventually Stop Dividing
The mechanism behind the Hayflick limit centers on telomeres, the protective caps at the ends of chromosomes. Each time a cell divides, its telomeres get slightly shorter. Once they erode past a critical length, the cell triggers an alarm that halts further division. This state of permanent arrest is called replicative senescence.4PubMed Central. Substrate stiffness dictates unique paths towards proliferative arrest in WI-38 cells
Research using WI-38 cells has helped map out the molecular details of this process. The arrest is enforced mainly through two signaling pathways involving the proteins p53, p21, p16, and pRb. When telomeres shorten enough, these proteins ramp up and essentially lock the cell out of its normal division cycle. Interestingly, environmental conditions in the culture dish can speed up or slow down this process. For example, selenium levels in the growth medium affect how quickly WI-38 cells reach senescence. Higher selenium concentrations helped maintain telomere length and significantly reduced the levels of those cell-cycle-arrest proteins, while selenium depletion pushed cells toward senescence faster.5Journal of Biological Chemistry. Selenium levels control the replicative life span of human diploid fibroblasts by regulating the entry into senescence Findings like these suggest that the Hayflick limit is not simply a fixed countdown but is influenced by the biochemical environment surrounding the cell.
Vaccines Made Possible by WI-38
The most consequential practical use of WI-38 cells has been in vaccine manufacturing. The rubella vaccine provides the clearest example. During the massive rubella epidemic of 1964, researchers at the Wistar Institute isolated the rubella virus directly from tissue of a fetus affected by the disease. The virus strain, designated RA 27/3, was then grown and weakened (attenuated) in WI-38 cells. This approach was deliberately chosen to avoid the problem of contamination by stray animal viruses, which plagued earlier vaccine production methods that relied on monkey kidney cells.6JAMA Pediatrics. Attenuation of RA 27/3 Rubella Virus in WI-38 Human Diploid Cells
The RA 27/3 rubella vaccine became the standard worldwide and remains part of the MMR (measles-mumps-rubella) combination vaccine given to children today. WI-38 cells were also used to produce vaccines against other diseases, including rabies and adenovirus. The cell strain’s clean genetic history, its well-documented safety profile, and its ability to support the growth of a wide range of human viruses made it uniquely suited for this purpose.1AIMS Press. The Role of the WI-38 Cell Strain in Saving Lives and Reducing Morbidity
Quality Control and Safety Testing
For a cell strain to be used in vaccine production, regulators demand extensive proof that the cells are genetically stable and free of contaminating agents. WI-38 cells were subjected to rigorous chromosome analysis before being approved for use. In evaluations involving more than 2,000 individual cells, researchers examined chromosome counts, looked for breaks and rearrangements, and performed full karyotype analysis when any abnormality was flagged. With one exception, the chromosome abnormalities found did not exceed the established limits of acceptability.7PubMed. Karyological characterization of WI-38 cells used in the production of vaccines
This kind of monitoring was not a one-time event. Because WI-38 cells have a finite lifespan, manufacturers work from a master cell bank: a large collection of frozen vials prepared at a known, early passage number. When a new batch of vaccine is needed, a vial is thawed and expanded. The cells used in the final production step are always within a well-characterized range of doublings, which keeps the genetic profile predictable. This banking system was itself an innovation that grew out of Hayflick’s work with WI-38 and became the model for how cell substrates are managed in the vaccine industry.
How WI-38 Compares to Other Cell Strains
WI-38 is not the only human diploid cell strain used in research and manufacturing. MRC-5, derived from fetal lung tissue in 1966, and IMR-90, established in 1975, are its closest relatives in function. A head-to-head comparison of all three strains for virus isolation found that viral recovery rates were similar across the board, and the speed and appearance of viral damage to the cells were comparable. However, their practical lifespans differed. MRC-5 and WI-38 cells remained healthy through about 36 generations, while IMR-90 cells went into crisis by generation 20. That longer working lifespan made MRC-5 a practical successor for many routine laboratory applications as original WI-38 stocks became scarce.8PubMed Central. Comparison of WI-38, MRC-5, and IMR-90 cell strains for isolation of viruses from clinical specimens
Despite the availability of alternatives, WI-38 remains the historical reference point. Many regulatory frameworks and safety standards for human diploid cell substrates were built around its characterization. And because aging researchers value the massive body of existing data on WI-38’s behavior over decades of study, the strain continues to be used in basic research even when newer strains could technically serve.
WI-38 in Modern Aging and Senescence Research
The fact that WI-38 cells reliably enter senescence after a predictable number of doublings has made them a standard model for studying what happens to cells as they age. This goes beyond simply counting divisions. Senescent cells are not just inactive; they actively change their behavior in ways that affect the tissue around them.
Research using WI-38 and related strains showed that when cells become senescent, they begin secreting a complex cocktail of inflammatory signals, growth factors, and enzymes. This behavior, called the senescence-associated secretory phenotype, was characterized using multiple fibroblast strains including WI-38 and IMR-90. Researchers made senescent cultures either by letting cells exhaust their replicative capacity or by exposing them to radiation, then analyzed the proteins the cells released into the surrounding medium. The secretory profile changed dramatically in senescent cells compared to their younger, still-dividing counterparts.9PLoS Biology. Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor This discovery has had major implications for understanding age-related diseases, because it means senescent cells are not just passively sitting around but are actively contributing to chronic inflammation and tissue deterioration.
WI-38 cells have also been used in the search for drugs that can selectively kill senescent cells, known as senolytics. One study screened a compound called piperlongumine and found it preferentially killed senescent WI-38 fibroblasts while sparing their younger counterparts. The effect held regardless of how senescence was triggered, whether by radiation, by exhausting the cells’ replicative capacity, or by forcing the expression of a cancer-promoting gene.10PubMed Central. Discovery of piperlongumine as a potential novel lead for the development of senolytic agents The idea behind senolytics is that clearing out senescent cells from aging tissues could reduce the chronic inflammation they cause and potentially slow aspects of aging. WI-38 cells serve as one of the primary test systems for evaluating whether candidate drugs can actually do this.
Ethical Concerns and Common Misconceptions
Because WI-38 cells originated from an electively aborted fetus, their use in vaccine production has been a persistent source of ethical debate, particularly among people with religious objections to abortion. This concern resurfaced during the COVID-19 pandemic, when questions about fetal cell lines in vaccine development became a factor in vaccine hesitancy for some individuals.11PubMed Central. Helping patients with ethical concerns about COVID-19 vaccines in light of fetal cell lines used in some COVID-19 vaccines
A common misconception is that fetal tissue is used in the production of every batch of vaccine. The reality is that the original tissue was collected once, in 1962. All subsequent use of WI-38 involves descendants of those original cells, grown and banked over decades. No new fetal tissue is needed. Another misconception is that the vaccines themselves contain fetal cells. In fact, the cells serve as the environment in which the virus is grown; the final vaccine product is purified to remove cellular material. What remains in the end product, if anything, is trace quantities of residual cell DNA and protein, not intact cells.
Healthcare providers have been encouraged to understand these distinctions so they can address patient concerns accurately. The gap between what patients believe about fetal cell lines and what actually happens during manufacturing is wide enough that simply providing clear factual information can resolve many objections.12American Journal of Health-System Pharmacy. A review of fetal cell lines used during drug development: Focus on COVID-19 vaccines, transplant medications, and biologics Various religious authorities, including the Pontifical Academy for Life within the Catholic Church, have weighed in on whether the use of these vaccines is morally permissible, generally concluding that individuals may use them in good conscience when no alternative is available, particularly given the public health stakes.
How Physical Environment Shapes Cell Aging
One of the more recent and surprising findings from WI-38 research involves the physical stiffness of the surface on which cells are grown. Cells in the body sit on tissues with varying degrees of firmness, from the soft matrix of lung tissue to the rigid environment of bone. Researchers found that the stiffness of the growth substrate influences how WI-38 cells progress toward senescence, with different mechanical environments steering cells down distinct molecular paths toward the same endpoint of growth arrest.4PubMed Central. Substrate stiffness dictates unique paths towards proliferative arrest in WI-38 cells
This matters because most traditional cell culture is done on hard plastic dishes, which are far stiffer than anything found in a living body. If mechanical stiffness changes how cells age, then decades of senescence research may have been documenting a version of aging shaped partly by an artificial environment. The finding pushes the field to consider whether results obtained on rigid plastic surfaces fully reflect what happens in softer, more lifelike conditions. It also opens up the possibility that tissue stiffening, which occurs naturally in many organs as people age, could itself be a driver of cellular senescence in vivo rather than just a passive consequence of it.
WI-38’s Role in Virus Isolation Beyond Vaccines
WI-38 cells have not only been used to produce vaccines but also to detect and isolate viruses from patient samples in diagnostic laboratories. Because these cells are human-derived and support the growth of a broad range of respiratory viruses, they became a go-to substrate for clinical virology. Studies in the late 1970s and beyond demonstrated that human embryonic lung cell clones, similar to WI-38, showed susceptibility to rhinoviruses, coronaviruses, adenoviruses, and respiratory syncytial virus, with individual clones varying in how readily they supported different virus types.13PubMed Central. Clones of cells from a human embryo lung: their growth and susceptibility to respiratory viruses
This variability across clones was itself a useful finding, because it meant labs could select specific cell clones optimized for detecting the viruses they were most interested in. In routine diagnostic work, WI-38 cells served as a reliable general-purpose substrate. As the original WI-38 stocks became harder to obtain, MRC-5 cells increasingly took over this role in clinical labs, but the protocols and workflows were developed around WI-38’s performance characteristics.
Why a Single Cell Strain Still Matters Six Decades Later
It is unusual for a biological reagent developed in the early 1960s to remain relevant in active research, but WI-38 occupies a unique position. In vaccine manufacturing, the strain’s documented safety record spanning more than half a century gives it a regulatory credibility that newer cell substrates struggle to match. In aging research, the sheer volume of published data on WI-38’s behavior at every stage from early growth to deep senescence makes it an irreplaceable reference standard. Researchers studying a new compound’s effect on cellular aging can compare their results directly against a baseline built up over thousands of experiments by labs around the world.
WI-38 also serves as a cautionary example of what happens when a finite biological resource is taken for granted. The original cell bank is not unlimited. Because the cells can only divide roughly 50 times, and every thaw and expansion consumes some of that capacity, the supply has been managed carefully. The establishment of complementary strains like MRC-5 was driven in part by the practical reality that WI-38 stocks would eventually run thin. Efforts to develop new cell substrates for vaccine production, including lines derived from different tissue types or engineered for extended lifespan, are ongoing, but each new candidate must pass the same exhaustive safety and characterization hurdles that WI-38 cleared decades ago. That process can take years, which is one reason why a cell strain from 1962 continues to be manufactured into vaccines shipped around the world today.